4/A: Standard BioTools Director Amends Beneficial Ownership Filing

Standard BioTools Director Troy Cox filed an amended Form 4 to correct the reported number of beneficially owned common stock shares to 319,322.

Summary

• The filing is an amendment (Form 4/A) to a previously filed Form 4.
• The sole purpose of this amendment is to correct the number of securities beneficially owned by Reporting Person Troy Cox as of June 20, 2025.
• The corrected number of Common Stock shares beneficially owned directly by Troy Cox is 319,322.
• All other information reported in the original Form 4 filed on June 24, 2025, remains unchanged.

Sentiment

Score: 5

Explanation: The filing is an amendment to correct a previously reported beneficial ownership number, indicating a clerical correction rather than a new event impacting company performance or outlook. It is neutral in sentiment.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This filing is a routine regulatory amendment related to insider beneficial ownership and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Provides updated, accurate information regarding a director's beneficial ownership, ensuring transparency and compliance with regulatory reporting requirements.

Key Dates

Keywords

Standard BioTools, LAB, Troy Cox, Form 4/A, beneficial ownership, insider trading, SEC filing, director, common stock